Concepedia

Joshua Garlich

JG

Statistics

Publications

1

Citations

12

H-Index

1

Active since

2022

Affiliations

Apellis Pharmaceuticals (United States)(Current)

Joshua Garlich is an author at Apellis Pharmaceuticals (United States) specializing in drug discovery, medicinal chemistry, and small-molecule complement inhibitors.

ORCID

Publications per year

2022–2022

1

Publications

1

Discovery of APL-1030, a Novel, High-Affinity Nanofitin Inhibitor of C3-Mediated Complement Activation

Joshua Garlich, Mathieu Cinier, Anne Chevrel et al. · Biomolecules · 2022 · 12 citations · Full text

, , +14

1–1 of 1